Published in Obesity and Diabetes Week, October 10th, 2005
The results of this study conducted in collaboration with XLHealth, a U.S. based disease management firm handling chronically ill patients for the U.S. Centers for Medicare and Medicaid Services (CMS), were presented at the 41st Annual Meeting of the European Association for the Study of Diabetes in Athens, Greece.
The randomized, double-blind, placebo-controlled, multi-center...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.